02-22-2008, 09:05 AM
|
#2
|
|
Status: IFFI Control Tower
Join Date: Jun 2007
Location: Rochester, NY / Baltimore, Md / Others
Posts: 2,186
|
I don't think I can say with certainty.
There is no precedent I am aware of. In other words, to date, we have seen many use propadrol with no estrogenic sides like poor libido, gyno, et al... In fact, pretty much the contrary with increased libido, "drying" out (decreased subcutaneous water), et al. That is all I can offer.
Still, I am of the camp that believes estrogenic sides ARE "possible" with all forms of hormonal manipulation - whether it is while running the agent and/or a direct/indirect HPTA-rebound effect in the aftermath. There are NO studies on the selected compound conglomerates "exactly," so this proves a difficult sell in either direction.
Anecdotally, agents that had suggested little gyno-potential have offered alternative effects. Take, 1,4 AD (BOLD, et al) - we have 4 case reports of gyno-induced reactions that do NOT appear dose-related, so it may be more an individual statistic more than anything (unsure).
So, while I hope this might have been helpful...its the best I have to date...so I apologize.
D_
__________________
Dana Houser, MD, MHSA, CISSN
askdinoiii@hotmail.com
The Clinical Underground Official Newsletter (Volume I, Issues I & II now available) ... send "subscribe" email to the address above.
Disclaimer: Despite my being a physician, the information provided in my posts is intended for INFORMATIONAL PURPOSES ONLY and to stimulate increased rapport between physician and patient. It is asked that you embark on advice provided solely by your EXAMINING physician.
Please do NOT email, PM for scripts or referral.
|
|
|
|